NEW YORK – Twist Bioscience said on Tuesday that it intends to offer shares of its common stock worth $250 million. Certain selling stockholders intend to offer 75,000 shares in the offering.
NEW YORK – Twist Bioscience said on Tuesday that it intends to offer shares of its common stock worth $250 million. Certain selling stockholders intend to offer 75,000 shares in the offering.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.